MiR-34a Chemosensitizes Bladder Cancer Cells to Cisplatin Treatment Regardless of P53-Rb Pathway Status
International Journal of Cancer - United States
doi 10.1002/ijc.26256
Full Text
Open PDFAbstract
Available in full text
Date
December 2, 2011
Authors
Publisher
Wiley